Multy Drugs Pvt Ltd

Founded in 1986 and headquartered in West Bengal, India.

1986 | Kolkata, West Bengal (India) | Merged
Last Updated: January 16, 2025

Multy Drugs Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.18 M
  • Company Age 38 Year, 6 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth %
  • Profit Growth -3.79%
  • Ebitda 40.97%
  • Net Worth -76.45%
  • Total Assets 0.02%

About Multy Drugs

Multy Drugs Pvt Ltd (MDPL) is Amalgamated company established on 28 Jul 1986 with its office registered at Kolkata, West Bengal, India and has been running since 38 Year, 6 Months with a paid up capital of 0.18 M. According to MCA records, 2 Directors are linked to this company as of 16 Jan 2025.

Company Details

  • Location

    Kolkata, West Bengal, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239WB1986PTC041015

  • Company No.

    041015

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    28 Jul 1986

  • Date of AGM

    13 Sep 2021

  • Date of Balance Sheet

    31 Mar 2021

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kolkata

Industry

Pharma

Who are the key members and board of directors at Multy Drugs?

Board Members (2)

NameDesignationAppointment DateStatus
Ramesh Ruia Country flag representing In Director 25-May-2001Current
Asim Agarwalla Country flag representing In Director 07-Jul-2007Current

Financial Performance of Multy Drugs.

Multy Drugs Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 76.45%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
0.02%
Profit or Loss
-3.79%
Net Worth
-76.45%
EBITDA
40.97%

What is the Ownership and Shareholding Structure of Multy Drugs?

In 2020, Multy Drugs had a promoter holding of 97.87% and a public holding of 2.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Multy Drugs?

Unlock and access historical data on people associated with Multy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Multy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Multy Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Multy Drugs

Recent activity within the organization

  • Annual General Meeting

    Multy Drugs Pvt Ltd last Annual general meeting of members was held on 13 Sep 2021 as per latest MCA records.

    13 Sep 2021

  • Balance Sheet

    Multy Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Kolkata.

    31 Mar 2021

  • Director Appointment

    Asim Kumar Agarwalla was appointed as a Director was appointed as a Director on 07 Jul 2007 & has been associated with this company since 17 years 7 months .

    07 Jul 2007

  • Director Appointment

    Ramesh Kumar Ruia was appointed as a Director was appointed as a Director on 25 May 2001 & has been associated with this company since 23 years 9 months .

    25 May 2001

  • Company Incorporation

    Multy Drugs Pvt Ltd was registered on 28 Jul 1986 with Roc Kolkata & aged 38 years 6 months as per MCA records.

    28 Jul 1986

Frequently asked questions

  • Multy Drugs Pvt Ltd was incorporated on 28 Jul 1986.

  • The authorized share capital of Multy Drugs Pvt Ltd is ₹ 0.50 M and paid-up capital is ₹ 0.18 M.

  • Currently 2 directors are associated with Multy Drugs Pvt Ltd.

    • Asim Kumar Agarwalla
    • Ramesh Kumar Ruia
  • As per Ministry of Corporate Affairs (Mca), the registered address of Multy Drugs Pvt Ltd is 239 A J C Bose Road India, Kolkata, West Bengal, 700020.

  • The corporate identification number (CIN) of Multy Drugs Pvt Ltd is U24239WB1986PTC041015 and the company number is 041015 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2021 indicates that The net worth of Multy Drugs Pvt Ltd has experienced an downturn of -76.45%.

  • The most recent Balance Sheet for Multy Drugs Pvt Ltd was filed with the ROC on 31 Mar 2021.

People also Viewed

Similar Companies Based on Drug Formulation & Development